How we treat endocrine complications of immune checkpoint inhibitors

por Paschou, S.A., Stefanaki, K., Psaltopoulou, T., Liontos, M., Koutsoukos, K., Zagouri, F., Lambrinoudaki, I., Dimopoulos, M.-A.
Publicado 2021

Comparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal women

por Augoulea, A., Tsakonas, E., Triantafyllopoulos, I., Rizos, D., Armeni, E., Tsoltos, N., Tournis, S., Deligeoroglou, E., Antoniou, A., Lambrinoudaki, I.
Publicado 2017

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

por Rozenberg, S., Al-Daghri, N., Aubertin-Leheudre, M., Brandi, M.-L., Cano, A., Collins, P., Cooper, C., Genazzani, A. R., Hillard, T., Kanis, J.A., Kaufman, J.-M., Lambrinoudaki, I., Laslop, A., McCloskey, E., Palacios, S., Prieto-Alhambra, D., Reginster, J.-Y., Rizzoli, R., Rosano, G., Trémollieres, F., Harvey, N.C.
Publicado 2020